This website uses cookies
Read our Privacy policy and Terms of use for more information.
Oct 16, 2026
•
1 min read
The FDA clearance expands twiist to people with type 2 diabetes using insulin, following trial results showing improved time in range and A1c.
Oct 14, 2026
Tandem says a software issue may prevent the immediate portion of Extended Boluses from being delivered to users of the Android app.
Oct 12, 2026
Insulet's diabetes data platform gives Omnipod 5 users and healthcare professionals personalized insights into glucose trends, insulin delivery, and therapy.
Oct 9, 2026
The glucose monitoring startup has secured new funding and partnered with Ascensia to bring its next-generation microsensor CGM to Europe.
Oct 6, 2026
Biolinq’s needle-free will soon be available OTC for adults not using insulin, expanding access to continuous glucose insights without a prescription.
Oct 5, 2026
twiist adds insulin pump control to two Android phones and smartwatches, giving more users access to the highly customizable app-controlled AID system.
Sep 28, 2026
Tandem’s smallest AID system expands overseas as the company works toward new CGM integrations, Android support, and a tubeless Mobi.
The all-in-one Libre App has rolled out internationally, expanding access to the Libre 2 and Libre 3 Plus, and an expanded feature set.
Sep 21, 2026
The open-source AID system latest updated brings upgraded features, including new CGM and pump integrations.
Sep 14, 2026
The Eversense 365 implantable continuous glucose monitor will expand support to a second insulin pump before the end of the year.
Sep 1, 2026
MiniMed's first tubeless insulin pump could reach the market by summer 2027, and a fully closed-loop algorithm is expected soon after.
Aug 25, 2026
The newly authorized Libre Duo 10 Day will continuously track both glucose and ketones, potentially giving people with diabetes an earlier warning of rising ketone levels.
Aug 17, 2026
Compatibility between the Instinct sensor and MiniMed Flex insulin pump gives users more sensor options for their diabetes management.
Aug 11, 2026
The insulin pump company is expanding access to pumps by tapping into new European markets and offering pay-as-you-go benefit options for U.S. customers.
Jul 22, 2026
The update expands access to MiniMed's latest pump, with its sensor portfolio, helping reduce the day to day burden of diabetes for adults living with diabetes.
Jul 13, 2026
Canadian adults, 18 years and older, with diabetes will have access to Dexcom's sensor with the longest wear time, setting a new standard for the company.
Jul 6, 2026
Spain is the latest European market that now has access to Omnipod 5 and Insulet products, with more planned to come later this year.
Jun 23, 2026
The new sensor availability gives European markets access to the most current MiniMed automated insulin delivery and Smart multiple daily injections systems.
Jun 15, 2026
Dexcom's over-the-counter Stelo sensor is now available for adults and children who are not taking insulin to help improve glycemic awareness.
Jun 9, 2026
Dexcom released data at ADA 2026 showing Dexcom G7 improves glucose levels for people with type 2 diabetes compared to those using traditional blood glucose tests.
Jun 4, 2026
CeQur Simplicity wearable insulin patch is now approved for extended wear-time plus a new version with one unit dosing to help ease precision
Jun 3, 2026
Insulet is bringing a new target glucose of 100 mg/dL to Omnipod 5 to improve time in range and upgrades to increase time in automated mode.
Jun 2, 2026
Dexcom's Customer Advisory Council Report reveals user feedback and problems the the company has begun tackling to regain trust within the community.
Jun 1, 2026
The twiist insiights app updates come on the heels of several new twiist updates including alerts for followers, snooze options, sleep schedules, and more.
May 29, 2026
Afrezza, the only inhalable mealtime insulin, is now available to children and adolescents signifying a step forward in pediatric diabetes care
